SlideShare a Scribd company logo
Examples of evidence-supported
decisions
Prof. Marjukka Mäkelä, THL / FINOHTA
16 Jan 2014

Mäkelä – EUnetHTA Training

1
Evidence is
the best available answer
to a well-formulated question
that experts are able to produce
with good methods
in the time given

2
Getting evidence
into decisions…
...requires
collaboration
between HTA and
policy makers.
Two examples from
Finland

3
Case 1:
Hospital policies on liver dialysis
New device to treat liver failure: MARS®
(molecular adsorbents recirculating system)

Life-saving for certain cases of liver failure
Acute toxications (ALF)
Acute-on-chronic liver failure (AoCLF)
Bridging treatment when waiting for transplant

Should all central hospitals provide MARS®?
Merchants marketing actively

4
The MUMM program
Managed Uptake of Medical Methods

Joint program of all central hospitals in Finland + Finohta

Topics collected & selected twice yearly
Rapid HTAs (3-9 months) from Finohta
Reviewed & published in FMJ
MUMM Board decision on implementing technology
+ agreement on division of labour

5
Liver dialysis: Effect and cost
HTA (original systematic review)
7 RCTs (n = 230), 20 case series (n = 860)
Survival with conservative treatment 0 - 40%, with
MARS® 16 - 100%
Cost: Machine 18 000 €, filter 3 000 € (1/day)
High expertise required
In Finland 30 - 50 eligible patients per year

6
MUMM Policy decision on MARS®
National criteria for patient
selection
Close collaboration with
liver transplant unit
necessary
Treatment in one university
hospital (+2 backup)
Patient register & regular
reports of results
↓
A PhD thesis started on the
topic including CEA

7
Case 2: National policy
21 Jan 2011

Mäkelä CC seminar

8
Obesity surgery
•
•
•
•

MUMM suggestion in 2007
Important topic, spreading unevenly
Scoping: Major ethical issues
SII also asked for an HTA

→ Full HTA as basis for policies
• Effectiveness, safety, cost, ethical, social,
organisational and legal issues

9
Policy options
No operations (0-option)
1. Strict criteria: 1500 operations /year
2. International criteria, low demand: 3000/yr
3. International criteria, high demand: 6000/yr

Decision for payers

11
Each scenario considers
• Effects on health care system
• Effects on health
• Cost impact
• Focal points of
policy discussion
Scenario 2

12
Scenario 2 items
•
•
•
•
•
•
•

75 000 persons with morbid obesity
Willing and suitable for operation: 13 000
Spread over 5 years: 3000 operations yearly
Personnel need for operations: 105 py
Increased demand for treatment abroad /privately
10-20 operation induced deaths yearly
400 complications, 300 reoperations /yr

13
Prioritisation by point system
1. Strict criteria
BMI > 45: 50 pts
BMI 40-45: 40 pts
BMI 35-40: 30 pts

BMI points
2. International criteria
BMI > 40: 50 pts
BMI 35-40: 40 pts

Other points
Type 2 diabetes: 20 pts
Any other disease that
Medicated hypertension: 10 pts
obesity aggravates: 10 pts
Sleep apnea w. CPAP: 10 pts
Joint problem needing operation: 10 pts

50 points: Operation indicated
14
How does this translate to policy?
• Ministry decision on
criteria for elective
operations
• Social insurance
decision on coverage
Same principles for
public and private care

15
Two successful examples -why?
Policy making structures in place
Clear customers for HTA report
Inclusive process of HTA and decision making
Collaboration and mutual trust between decision
makers, clinicians and methodologists
Sufficiently rapid reply - patience to wait for it

16
Evidence into
decisions:
Barriers
Policy makers ask wrong
questions
Researchers aim at
perfect answers
They disagree on timing
→ Need to develop a
shared understanding
of HTA use in policy
17
Policy implementation:
a major challenge
HTA producers provide data, not policies
May participate in policy formation as
experts

Post HTA report implementation: national
seminar, participation in formulating legislation,
national training, producing patient leaflets, web
learning materials, effect assessment...

18
Values

Decision
Evidence

Resources

JA Muir Gray: Evidence Based Health Policy
Churchill Livingstone, London 2002
19
Evidence does
not make
decisions.
People do.

20
Thank you!

21 Jan 2011

Mäkelä CC seminar

21

More Related Content

What's hot

Do nice decisions affect decisions in other countries ht ai
Do nice decisions affect decisions in other countries  ht aiDo nice decisions affect decisions in other countries  ht ai
Do nice decisions affect decisions in other countries ht ai
Office of Health Economics
 
Towards a Value Framework for Antibiotics
Towards a Value Framework for AntibioticsTowards a Value Framework for Antibiotics
Towards a Value Framework for Antibiotics
Office of Health Economics
 
Towse NDDP implications for drug development
Towse NDDP implications for drug developmentTowse NDDP implications for drug development
Towse NDDP implications for drug development
Office of Health Economics
 
2017 and beyond
2017 and beyond2017 and beyond
Moving towards value based funding
Moving towards value based fundingMoving towards value based funding
Moving towards value based funding
Independent Hospital Pricing Authority
 
Establishing a Reasonable Price for an Orphan Drug
Establishing a Reasonable Price for an Orphan DrugEstablishing a Reasonable Price for an Orphan Drug
Establishing a Reasonable Price for an Orphan Drug
Office of Health Economics
 
Developing and Paying for Gene Therapies: Can We Resolve the Conflicts? A Eur...
Developing and Paying for Gene Therapies: Can We Resolve the Conflicts? A Eur...Developing and Paying for Gene Therapies: Can We Resolve the Conflicts? A Eur...
Developing and Paying for Gene Therapies: Can We Resolve the Conflicts? A Eur...
Office of Health Economics
 
Multi-indication Pricing: Do we want it? Can we Personalize it?
Multi-indication Pricing: Do we want it? Can we Personalize it?Multi-indication Pricing: Do we want it? Can we Personalize it?
Multi-indication Pricing: Do we want it? Can we Personalize it?
Office of Health Economics
 
The Value of Targeted Sequencing in Advanced Cancer: DCE to Elicit the Public...
The Value of Targeted Sequencing in Advanced Cancer: DCE to Elicit the Public...The Value of Targeted Sequencing in Advanced Cancer: DCE to Elicit the Public...
The Value of Targeted Sequencing in Advanced Cancer: DCE to Elicit the Public...
Office of Health Economics
 
Advanced Therapy Medicinal Products: Are Current HTA Methods Suitable?
Advanced Therapy Medicinal Products: Are Current HTA Methods Suitable?Advanced Therapy Medicinal Products: Are Current HTA Methods Suitable?
Advanced Therapy Medicinal Products: Are Current HTA Methods Suitable?
Office of Health Economics
 
Effects of the 2016 pharmaceutical reimbursement scheme changes – a microsimu...
Effects of the 2016 pharmaceutical reimbursement scheme changes – a microsimu...Effects of the 2016 pharmaceutical reimbursement scheme changes – a microsimu...
Effects of the 2016 pharmaceutical reimbursement scheme changes – a microsimu...
TITA research
 
Does patient engagement result in more appropriate utilization?
Does patient engagement result in more appropriate utilization?Does patient engagement result in more appropriate utilization?
Does patient engagement result in more appropriate utilization?
Benjamin Littenberg
 
Establishing a Fair Price for an Orphan Drug by Mikel Berdud et al.
Establishing a Fair Price for an Orphan Drug by Mikel Berdud et al.Establishing a Fair Price for an Orphan Drug by Mikel Berdud et al.
Establishing a Fair Price for an Orphan Drug by Mikel Berdud et al.
Office of Health Economics
 
HTA Training - Yvonne Hughes, CF Trust UK - July 26th 2016
HTA Training - Yvonne Hughes, CF Trust UK - July 26th 2016HTA Training - Yvonne Hughes, CF Trust UK - July 26th 2016
HTA Training - Yvonne Hughes, CF Trust UK - July 26th 2016
ipposi
 
Balancing needs and resources in medicines delivery
Balancing needs and resources in medicines delivery Balancing needs and resources in medicines delivery
Balancing needs and resources in medicines delivery
Irish Pharmaceutical Healthcare Association (IPHA)
 
How diagnostics can drive efficiency within the NHS
How diagnostics can drive efficiency within the NHSHow diagnostics can drive efficiency within the NHS
How diagnostics can drive efficiency within the NHS
Walt Whitman
 
UK AMR Diagnositics Collaborative
UK AMR Diagnositics CollaborativeUK AMR Diagnositics Collaborative
UK AMR Diagnositics Collaborative
Walt Whitman
 
Emergency care costing study and classification development
Emergency care costing study and classification developmentEmergency care costing study and classification development
Emergency care costing study and classification development
Independent Hospital Pricing Authority
 
Pichler get real at ht ai- introduction
Pichler get real at  ht ai- introductionPichler get real at  ht ai- introduction
Pichler get real at ht ai- introduction
Office of Health Economics
 
Health economics and causal modelling in Health Services Research
Health economics and causal modelling in Health Services ResearchHealth economics and causal modelling in Health Services Research
Health economics and causal modelling in Health Services Research
NIHR CLAHRC West Midlands
 

What's hot (20)

Do nice decisions affect decisions in other countries ht ai
Do nice decisions affect decisions in other countries  ht aiDo nice decisions affect decisions in other countries  ht ai
Do nice decisions affect decisions in other countries ht ai
 
Towards a Value Framework for Antibiotics
Towards a Value Framework for AntibioticsTowards a Value Framework for Antibiotics
Towards a Value Framework for Antibiotics
 
Towse NDDP implications for drug development
Towse NDDP implications for drug developmentTowse NDDP implications for drug development
Towse NDDP implications for drug development
 
2017 and beyond
2017 and beyond2017 and beyond
2017 and beyond
 
Moving towards value based funding
Moving towards value based fundingMoving towards value based funding
Moving towards value based funding
 
Establishing a Reasonable Price for an Orphan Drug
Establishing a Reasonable Price for an Orphan DrugEstablishing a Reasonable Price for an Orphan Drug
Establishing a Reasonable Price for an Orphan Drug
 
Developing and Paying for Gene Therapies: Can We Resolve the Conflicts? A Eur...
Developing and Paying for Gene Therapies: Can We Resolve the Conflicts? A Eur...Developing and Paying for Gene Therapies: Can We Resolve the Conflicts? A Eur...
Developing and Paying for Gene Therapies: Can We Resolve the Conflicts? A Eur...
 
Multi-indication Pricing: Do we want it? Can we Personalize it?
Multi-indication Pricing: Do we want it? Can we Personalize it?Multi-indication Pricing: Do we want it? Can we Personalize it?
Multi-indication Pricing: Do we want it? Can we Personalize it?
 
The Value of Targeted Sequencing in Advanced Cancer: DCE to Elicit the Public...
The Value of Targeted Sequencing in Advanced Cancer: DCE to Elicit the Public...The Value of Targeted Sequencing in Advanced Cancer: DCE to Elicit the Public...
The Value of Targeted Sequencing in Advanced Cancer: DCE to Elicit the Public...
 
Advanced Therapy Medicinal Products: Are Current HTA Methods Suitable?
Advanced Therapy Medicinal Products: Are Current HTA Methods Suitable?Advanced Therapy Medicinal Products: Are Current HTA Methods Suitable?
Advanced Therapy Medicinal Products: Are Current HTA Methods Suitable?
 
Effects of the 2016 pharmaceutical reimbursement scheme changes – a microsimu...
Effects of the 2016 pharmaceutical reimbursement scheme changes – a microsimu...Effects of the 2016 pharmaceutical reimbursement scheme changes – a microsimu...
Effects of the 2016 pharmaceutical reimbursement scheme changes – a microsimu...
 
Does patient engagement result in more appropriate utilization?
Does patient engagement result in more appropriate utilization?Does patient engagement result in more appropriate utilization?
Does patient engagement result in more appropriate utilization?
 
Establishing a Fair Price for an Orphan Drug by Mikel Berdud et al.
Establishing a Fair Price for an Orphan Drug by Mikel Berdud et al.Establishing a Fair Price for an Orphan Drug by Mikel Berdud et al.
Establishing a Fair Price for an Orphan Drug by Mikel Berdud et al.
 
HTA Training - Yvonne Hughes, CF Trust UK - July 26th 2016
HTA Training - Yvonne Hughes, CF Trust UK - July 26th 2016HTA Training - Yvonne Hughes, CF Trust UK - July 26th 2016
HTA Training - Yvonne Hughes, CF Trust UK - July 26th 2016
 
Balancing needs and resources in medicines delivery
Balancing needs and resources in medicines delivery Balancing needs and resources in medicines delivery
Balancing needs and resources in medicines delivery
 
How diagnostics can drive efficiency within the NHS
How diagnostics can drive efficiency within the NHSHow diagnostics can drive efficiency within the NHS
How diagnostics can drive efficiency within the NHS
 
UK AMR Diagnositics Collaborative
UK AMR Diagnositics CollaborativeUK AMR Diagnositics Collaborative
UK AMR Diagnositics Collaborative
 
Emergency care costing study and classification development
Emergency care costing study and classification developmentEmergency care costing study and classification development
Emergency care costing study and classification development
 
Pichler get real at ht ai- introduction
Pichler get real at  ht ai- introductionPichler get real at  ht ai- introduction
Pichler get real at ht ai- introduction
 
Health economics and causal modelling in Health Services Research
Health economics and causal modelling in Health Services ResearchHealth economics and causal modelling in Health Services Research
Health economics and causal modelling in Health Services Research
 

Viewers also liked

Evaluation of the Hepa Wash treatment in pigs with acute liver failure
Evaluation of the Hepa Wash treatment in pigs  with acute liver failureEvaluation of the Hepa Wash treatment in pigs  with acute liver failure
Evaluation of the Hepa Wash treatment in pigs with acute liver failure
Enrique Moreno Gonzalez
 
Adrian Gadano - Argentina - Tuesday 29 - Liver Transplantation Towards New H...
Adrian Gadano  - Argentina - Tuesday 29 - Liver Transplantation Towards New H...Adrian Gadano  - Argentina - Tuesday 29 - Liver Transplantation Towards New H...
Adrian Gadano - Argentina - Tuesday 29 - Liver Transplantation Towards New H...incucai_isodp
 
Management of hepatic encephalopathy
Management of hepatic encephalopathy Management of hepatic encephalopathy
Management of hepatic encephalopathy drnkhokhar
 
152203601 liver-cirrhosis
152203601 liver-cirrhosis152203601 liver-cirrhosis
152203601 liver-cirrhosis
homeworkping4
 
Extracorporeal liver support therapies
Extracorporeal liver support therapies Extracorporeal liver support therapies
Extracorporeal liver support therapies
Ayman Seddik
 
Is it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. GawadIs it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. Gawad
NephroTube - Dr.Gawad
 
Acute Liver Failure Update
Acute Liver Failure UpdateAcute Liver Failure Update
Acute Liver Failure Update
Palepu BN Gopal
 

Viewers also liked (7)

Evaluation of the Hepa Wash treatment in pigs with acute liver failure
Evaluation of the Hepa Wash treatment in pigs  with acute liver failureEvaluation of the Hepa Wash treatment in pigs  with acute liver failure
Evaluation of the Hepa Wash treatment in pigs with acute liver failure
 
Adrian Gadano - Argentina - Tuesday 29 - Liver Transplantation Towards New H...
Adrian Gadano  - Argentina - Tuesday 29 - Liver Transplantation Towards New H...Adrian Gadano  - Argentina - Tuesday 29 - Liver Transplantation Towards New H...
Adrian Gadano - Argentina - Tuesday 29 - Liver Transplantation Towards New H...
 
Management of hepatic encephalopathy
Management of hepatic encephalopathy Management of hepatic encephalopathy
Management of hepatic encephalopathy
 
152203601 liver-cirrhosis
152203601 liver-cirrhosis152203601 liver-cirrhosis
152203601 liver-cirrhosis
 
Extracorporeal liver support therapies
Extracorporeal liver support therapies Extracorporeal liver support therapies
Extracorporeal liver support therapies
 
Is it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. GawadIs it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. Gawad
 
Acute Liver Failure Update
Acute Liver Failure UpdateAcute Liver Failure Update
Acute Liver Failure Update
 

Similar to EUnetHTA Training course for Stakeholders - Examples of evidence-supported decisions (Kristian LAMPE)

New Medicine Evaluation, Scottish Medicines Consortium
New Medicine Evaluation, Scottish Medicines ConsortiumNew Medicine Evaluation, Scottish Medicines Consortium
New Medicine Evaluation, Scottish Medicines Consortium
European Industrial Pharmacists Group
 
Medication Reconciliation – time to rethink informatics support ? Trillium II...
Medication Reconciliation – time to rethink informatics support ? Trillium II...Medication Reconciliation – time to rethink informatics support ? Trillium II...
Medication Reconciliation – time to rethink informatics support ? Trillium II...
Trillium Bridge: Reinforcing the Bridges and Scaling up EU/US Cooperation on Patient Summary
 
2o OTC & Cosmetics Conference, Raymond Anderson
2o OTC & Cosmetics Conference, Raymond Anderson2o OTC & Cosmetics Conference, Raymond Anderson
2o OTC & Cosmetics Conference, Raymond Anderson
Starttech Ventures
 
Andrew innes hull wsdan 30 june 2011a
Andrew innes hull wsdan 30 june 2011aAndrew innes hull wsdan 30 june 2011a
Andrew innes hull wsdan 30 june 2011a3GDR
 
Supporting medicines adherence developing the pharmacist contribution
Supporting medicines adherence   developing the pharmacist contributionSupporting medicines adherence   developing the pharmacist contribution
Supporting medicines adherence developing the pharmacist contributionPM Society
 
Outcome Measures in Cancer: Do disease specific instruments offer greater sen...
Outcome Measures in Cancer: Do disease specific instruments offer greater sen...Outcome Measures in Cancer: Do disease specific instruments offer greater sen...
Outcome Measures in Cancer: Do disease specific instruments offer greater sen...
Office of Health Economics
 
iHT2 Health IT Summit Atlanta - Ronald Paulus, President & CEO, Mission Healt...
iHT2 Health IT Summit Atlanta - Ronald Paulus, President & CEO, Mission Healt...iHT2 Health IT Summit Atlanta - Ronald Paulus, President & CEO, Mission Healt...
iHT2 Health IT Summit Atlanta - Ronald Paulus, President & CEO, Mission Healt...
Health IT Conference – iHT2
 
Integrated care and support
Integrated care and supportIntegrated care and support
Integrated care and support
NHS Improving Quality
 
Aine Carroll, National Director of Clinical Strategy & Programmes, HSE
Aine Carroll, National Director of Clinical Strategy & Programmes, HSEAine Carroll, National Director of Clinical Strategy & Programmes, HSE
Aine Carroll, National Director of Clinical Strategy & Programmes, HSE
Investnet
 
Meaningful Use Workgroup Recommendations
Meaningful Use Workgroup Recommendations Meaningful Use Workgroup Recommendations
Meaningful Use Workgroup Recommendations Brian Ahier
 
Hugh Gravelle: The impact of care quality on patient choice
Hugh Gravelle: The impact of care quality on patient choiceHugh Gravelle: The impact of care quality on patient choice
Hugh Gravelle: The impact of care quality on patient choiceNuffield Trust
 
Introduction of the NZ Health IT Plan enables better gout management
Introduction of the NZ Health IT Plan enables better gout managementIntroduction of the NZ Health IT Plan enables better gout management
Introduction of the NZ Health IT Plan enables better gout management
Health Informatics New Zealand
 
ICN Victoria: Gantner on "Translating Research into Practice"
ICN Victoria: Gantner on "Translating Research into Practice"ICN Victoria: Gantner on "Translating Research into Practice"
ICN Victoria: Gantner on "Translating Research into Practice"
Intensive Care Network Victoria
 
MicroGuide app, pop up uni, 1pm, 3 september 2015
MicroGuide app, pop up uni, 1pm, 3 september 2015MicroGuide app, pop up uni, 1pm, 3 september 2015
MicroGuide app, pop up uni, 1pm, 3 september 2015
NHS England
 
7. Tom Lewis Getting it right for pathology presentation
7. Tom Lewis Getting it right for pathology presentation7. Tom Lewis Getting it right for pathology presentation
7. Tom Lewis Getting it right for pathology presentation
PHEScreening
 
Seeking value: Experience from the UK's National Institute for Health and Car...
Seeking value: Experience from the UK's National Institute for Health and Car...Seeking value: Experience from the UK's National Institute for Health and Car...
Seeking value: Experience from the UK's National Institute for Health and Car...
OECD Governance
 
Scn cvd-network-meeting-jan-2015
Scn cvd-network-meeting-jan-2015Scn cvd-network-meeting-jan-2015
Scn cvd-network-meeting-jan-2015
NHS Improving Quality
 
1115 gary mooney national health-conference-eire-may15
1115 gary mooney national health-conference-eire-may151115 gary mooney national health-conference-eire-may15
1115 gary mooney national health-conference-eire-may15
investnethealthcare
 
EuroBioForum2014_speaker_Love
EuroBioForum2014_speaker_LoveEuroBioForum2014_speaker_Love
EuroBioForum2014_speaker_Love
EuroBioForum
 

Similar to EUnetHTA Training course for Stakeholders - Examples of evidence-supported decisions (Kristian LAMPE) (20)

New Medicine Evaluation, Scottish Medicines Consortium
New Medicine Evaluation, Scottish Medicines ConsortiumNew Medicine Evaluation, Scottish Medicines Consortium
New Medicine Evaluation, Scottish Medicines Consortium
 
Medication Reconciliation – time to rethink informatics support ? Trillium II...
Medication Reconciliation – time to rethink informatics support ? Trillium II...Medication Reconciliation – time to rethink informatics support ? Trillium II...
Medication Reconciliation – time to rethink informatics support ? Trillium II...
 
2o OTC & Cosmetics Conference, Raymond Anderson
2o OTC & Cosmetics Conference, Raymond Anderson2o OTC & Cosmetics Conference, Raymond Anderson
2o OTC & Cosmetics Conference, Raymond Anderson
 
Andrew innes hull wsdan 30 june 2011a
Andrew innes hull wsdan 30 june 2011aAndrew innes hull wsdan 30 june 2011a
Andrew innes hull wsdan 30 june 2011a
 
Supporting medicines adherence developing the pharmacist contribution
Supporting medicines adherence   developing the pharmacist contributionSupporting medicines adherence   developing the pharmacist contribution
Supporting medicines adherence developing the pharmacist contribution
 
Outcome Measures in Cancer: Do disease specific instruments offer greater sen...
Outcome Measures in Cancer: Do disease specific instruments offer greater sen...Outcome Measures in Cancer: Do disease specific instruments offer greater sen...
Outcome Measures in Cancer: Do disease specific instruments offer greater sen...
 
iHT2 Health IT Summit Atlanta - Ronald Paulus, President & CEO, Mission Healt...
iHT2 Health IT Summit Atlanta - Ronald Paulus, President & CEO, Mission Healt...iHT2 Health IT Summit Atlanta - Ronald Paulus, President & CEO, Mission Healt...
iHT2 Health IT Summit Atlanta - Ronald Paulus, President & CEO, Mission Healt...
 
Integrated care and support
Integrated care and supportIntegrated care and support
Integrated care and support
 
Aine Carroll, National Director of Clinical Strategy & Programmes, HSE
Aine Carroll, National Director of Clinical Strategy & Programmes, HSEAine Carroll, National Director of Clinical Strategy & Programmes, HSE
Aine Carroll, National Director of Clinical Strategy & Programmes, HSE
 
Meaningful Use Workgroup Recommendations
Meaningful Use Workgroup Recommendations Meaningful Use Workgroup Recommendations
Meaningful Use Workgroup Recommendations
 
Hugh Gravelle: The impact of care quality on patient choice
Hugh Gravelle: The impact of care quality on patient choiceHugh Gravelle: The impact of care quality on patient choice
Hugh Gravelle: The impact of care quality on patient choice
 
Introduction of the NZ Health IT Plan enables better gout management
Introduction of the NZ Health IT Plan enables better gout managementIntroduction of the NZ Health IT Plan enables better gout management
Introduction of the NZ Health IT Plan enables better gout management
 
ICN Victoria: Gantner on "Translating Research into Practice"
ICN Victoria: Gantner on "Translating Research into Practice"ICN Victoria: Gantner on "Translating Research into Practice"
ICN Victoria: Gantner on "Translating Research into Practice"
 
MicroGuide app, pop up uni, 1pm, 3 september 2015
MicroGuide app, pop up uni, 1pm, 3 september 2015MicroGuide app, pop up uni, 1pm, 3 september 2015
MicroGuide app, pop up uni, 1pm, 3 september 2015
 
7. Tom Lewis Getting it right for pathology presentation
7. Tom Lewis Getting it right for pathology presentation7. Tom Lewis Getting it right for pathology presentation
7. Tom Lewis Getting it right for pathology presentation
 
Andrew Searles
Andrew SearlesAndrew Searles
Andrew Searles
 
Seeking value: Experience from the UK's National Institute for Health and Car...
Seeking value: Experience from the UK's National Institute for Health and Car...Seeking value: Experience from the UK's National Institute for Health and Car...
Seeking value: Experience from the UK's National Institute for Health and Car...
 
Scn cvd-network-meeting-jan-2015
Scn cvd-network-meeting-jan-2015Scn cvd-network-meeting-jan-2015
Scn cvd-network-meeting-jan-2015
 
1115 gary mooney national health-conference-eire-may15
1115 gary mooney national health-conference-eire-may151115 gary mooney national health-conference-eire-may15
1115 gary mooney national health-conference-eire-may15
 
EuroBioForum2014_speaker_Love
EuroBioForum2014_speaker_LoveEuroBioForum2014_speaker_Love
EuroBioForum2014_speaker_Love
 

More from EUnetHTA

How can patients and providers best contribute to the HTA process?
How can patients and providers best contribute to the HTA process?How can patients and providers best contribute to the HTA process?
How can patients and providers best contribute to the HTA process?
EUnetHTA
 
How to use the EUnetHTA submission template to support production of core Hea...
How to use the EUnetHTA submission template to support production of core Hea...How to use the EUnetHTA submission template to support production of core Hea...
How to use the EUnetHTA submission template to support production of core Hea...
EUnetHTA
 
The HTA Core Model® A brief introduction
The HTA Core Model® A brief introduction The HTA Core Model® A brief introduction
The HTA Core Model® A brief introduction
EUnetHTA
 
How to use HTA for decision-making based on HTA Core Information
How to use HTA for decision-making based on HTA Core InformationHow to use HTA for decision-making based on HTA Core Information
How to use HTA for decision-making based on HTA Core Information
EUnetHTA
 
Brief introduction to EUnetHTA and its tools
Brief introduction to EUnetHTA and its toolsBrief introduction to EUnetHTA and its tools
Brief introduction to EUnetHTA and its tools
EUnetHTA
 
EUnetHTA Training course for Stakeholders - Key principles of Health Technolo...
EUnetHTA Training course for Stakeholders - Key principles of Health Technolo...EUnetHTA Training course for Stakeholders - Key principles of Health Technolo...
EUnetHTA Training course for Stakeholders - Key principles of Health Technolo...
EUnetHTA
 
EUnetHTA Training course for Stakeholders - How to use HTA for decision makin...
EUnetHTA Training course for Stakeholders - How to use HTA for decision makin...EUnetHTA Training course for Stakeholders - How to use HTA for decision makin...
EUnetHTA Training course for Stakeholders - How to use HTA for decision makin...
EUnetHTA
 
EUnetHTA Training course for Stakeholders - Introduction to the HTA Core Mode...
EUnetHTA Training course for Stakeholders - Introduction to the HTA Core Mode...EUnetHTA Training course for Stakeholders - Introduction to the HTA Core Mode...
EUnetHTA Training course for Stakeholders - Introduction to the HTA Core Mode...
EUnetHTA
 
EUnetHTA Training course for Stakeholders - Brief introduction to EUnetHTA
EUnetHTA Training course for Stakeholders - Brief introduction to EUnetHTAEUnetHTA Training course for Stakeholders - Brief introduction to EUnetHTA
EUnetHTA Training course for Stakeholders - Brief introduction to EUnetHTA
EUnetHTA
 
EUnetHTA Planned and Ongoing Projects database (2014)
EUnetHTA Planned and Ongoing Projects database (2014)EUnetHTA Planned and Ongoing Projects database (2014)
EUnetHTA Planned and Ongoing Projects database (2014)
EUnetHTA
 
EUnetHTA Learning activities (2014)
EUnetHTA Learning activities (2014)EUnetHTA Learning activities (2014)
EUnetHTA Learning activities (2014)
EUnetHTA
 
EUnetHTA Training course for Stakeholders - Choice of Endpoints for Reimburse...
EUnetHTA Training course for Stakeholders - Choice of Endpoints forReimburse...EUnetHTA Training course for Stakeholders - Choice of Endpoints forReimburse...
EUnetHTA Training course for Stakeholders - Choice of Endpoints for Reimburse...
EUnetHTA
 
EUnetHTA Training course for Stakeholders - Brief introduction to EUnetHTA an...
EUnetHTA Training course for Stakeholders - Brief introduction to EUnetHTA an...EUnetHTA Training course for Stakeholders - Brief introduction to EUnetHTA an...
EUnetHTA Training course for Stakeholders - Brief introduction to EUnetHTA an...
EUnetHTA
 
EUnetHTA Training course for Stakeholders - HTA Core Model (r) (Kristian LAMPE)
EUnetHTA Training course for Stakeholders - HTA Core Model (r) (Kristian LAMPE)EUnetHTA Training course for Stakeholders - HTA Core Model (r) (Kristian LAMPE)
EUnetHTA Training course for Stakeholders - HTA Core Model (r) (Kristian LAMPE)
EUnetHTA
 
EUnetHTA Training course for Stakeholders - Patient involvement (Sophie WERKO)
EUnetHTA Training course for Stakeholders - Patient involvement (Sophie WERKO)EUnetHTA Training course for Stakeholders - Patient involvement (Sophie WERKO)
EUnetHTA Training course for Stakeholders - Patient involvement (Sophie WERKO)
EUnetHTA
 
EUnetHTA Joint Action 2 and long term strategy
EUnetHTA Joint Action 2 and long term strategyEUnetHTA Joint Action 2 and long term strategy
EUnetHTA Joint Action 2 and long term strategy
EUnetHTA
 
Results of the EUnetHTA Joint Action
Results of the EUnetHTA Joint ActionResults of the EUnetHTA Joint Action
Results of the EUnetHTA Joint Action
EUnetHTA
 

More from EUnetHTA (17)

How can patients and providers best contribute to the HTA process?
How can patients and providers best contribute to the HTA process?How can patients and providers best contribute to the HTA process?
How can patients and providers best contribute to the HTA process?
 
How to use the EUnetHTA submission template to support production of core Hea...
How to use the EUnetHTA submission template to support production of core Hea...How to use the EUnetHTA submission template to support production of core Hea...
How to use the EUnetHTA submission template to support production of core Hea...
 
The HTA Core Model® A brief introduction
The HTA Core Model® A brief introduction The HTA Core Model® A brief introduction
The HTA Core Model® A brief introduction
 
How to use HTA for decision-making based on HTA Core Information
How to use HTA for decision-making based on HTA Core InformationHow to use HTA for decision-making based on HTA Core Information
How to use HTA for decision-making based on HTA Core Information
 
Brief introduction to EUnetHTA and its tools
Brief introduction to EUnetHTA and its toolsBrief introduction to EUnetHTA and its tools
Brief introduction to EUnetHTA and its tools
 
EUnetHTA Training course for Stakeholders - Key principles of Health Technolo...
EUnetHTA Training course for Stakeholders - Key principles of Health Technolo...EUnetHTA Training course for Stakeholders - Key principles of Health Technolo...
EUnetHTA Training course for Stakeholders - Key principles of Health Technolo...
 
EUnetHTA Training course for Stakeholders - How to use HTA for decision makin...
EUnetHTA Training course for Stakeholders - How to use HTA for decision makin...EUnetHTA Training course for Stakeholders - How to use HTA for decision makin...
EUnetHTA Training course for Stakeholders - How to use HTA for decision makin...
 
EUnetHTA Training course for Stakeholders - Introduction to the HTA Core Mode...
EUnetHTA Training course for Stakeholders - Introduction to the HTA Core Mode...EUnetHTA Training course for Stakeholders - Introduction to the HTA Core Mode...
EUnetHTA Training course for Stakeholders - Introduction to the HTA Core Mode...
 
EUnetHTA Training course for Stakeholders - Brief introduction to EUnetHTA
EUnetHTA Training course for Stakeholders - Brief introduction to EUnetHTAEUnetHTA Training course for Stakeholders - Brief introduction to EUnetHTA
EUnetHTA Training course for Stakeholders - Brief introduction to EUnetHTA
 
EUnetHTA Planned and Ongoing Projects database (2014)
EUnetHTA Planned and Ongoing Projects database (2014)EUnetHTA Planned and Ongoing Projects database (2014)
EUnetHTA Planned and Ongoing Projects database (2014)
 
EUnetHTA Learning activities (2014)
EUnetHTA Learning activities (2014)EUnetHTA Learning activities (2014)
EUnetHTA Learning activities (2014)
 
EUnetHTA Training course for Stakeholders - Choice of Endpoints for Reimburse...
EUnetHTA Training course for Stakeholders - Choice of Endpoints forReimburse...EUnetHTA Training course for Stakeholders - Choice of Endpoints forReimburse...
EUnetHTA Training course for Stakeholders - Choice of Endpoints for Reimburse...
 
EUnetHTA Training course for Stakeholders - Brief introduction to EUnetHTA an...
EUnetHTA Training course for Stakeholders - Brief introduction to EUnetHTA an...EUnetHTA Training course for Stakeholders - Brief introduction to EUnetHTA an...
EUnetHTA Training course for Stakeholders - Brief introduction to EUnetHTA an...
 
EUnetHTA Training course for Stakeholders - HTA Core Model (r) (Kristian LAMPE)
EUnetHTA Training course for Stakeholders - HTA Core Model (r) (Kristian LAMPE)EUnetHTA Training course for Stakeholders - HTA Core Model (r) (Kristian LAMPE)
EUnetHTA Training course for Stakeholders - HTA Core Model (r) (Kristian LAMPE)
 
EUnetHTA Training course for Stakeholders - Patient involvement (Sophie WERKO)
EUnetHTA Training course for Stakeholders - Patient involvement (Sophie WERKO)EUnetHTA Training course for Stakeholders - Patient involvement (Sophie WERKO)
EUnetHTA Training course for Stakeholders - Patient involvement (Sophie WERKO)
 
EUnetHTA Joint Action 2 and long term strategy
EUnetHTA Joint Action 2 and long term strategyEUnetHTA Joint Action 2 and long term strategy
EUnetHTA Joint Action 2 and long term strategy
 
Results of the EUnetHTA Joint Action
Results of the EUnetHTA Joint ActionResults of the EUnetHTA Joint Action
Results of the EUnetHTA Joint Action
 

Recently uploaded

Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 

Recently uploaded (20)

Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 

EUnetHTA Training course for Stakeholders - Examples of evidence-supported decisions (Kristian LAMPE)

  • 1. Examples of evidence-supported decisions Prof. Marjukka Mäkelä, THL / FINOHTA 16 Jan 2014 Mäkelä – EUnetHTA Training 1
  • 2. Evidence is the best available answer to a well-formulated question that experts are able to produce with good methods in the time given 2
  • 3. Getting evidence into decisions… ...requires collaboration between HTA and policy makers. Two examples from Finland 3
  • 4. Case 1: Hospital policies on liver dialysis New device to treat liver failure: MARS® (molecular adsorbents recirculating system) Life-saving for certain cases of liver failure Acute toxications (ALF) Acute-on-chronic liver failure (AoCLF) Bridging treatment when waiting for transplant Should all central hospitals provide MARS®? Merchants marketing actively 4
  • 5. The MUMM program Managed Uptake of Medical Methods Joint program of all central hospitals in Finland + Finohta Topics collected & selected twice yearly Rapid HTAs (3-9 months) from Finohta Reviewed & published in FMJ MUMM Board decision on implementing technology + agreement on division of labour 5
  • 6. Liver dialysis: Effect and cost HTA (original systematic review) 7 RCTs (n = 230), 20 case series (n = 860) Survival with conservative treatment 0 - 40%, with MARS® 16 - 100% Cost: Machine 18 000 €, filter 3 000 € (1/day) High expertise required In Finland 30 - 50 eligible patients per year 6
  • 7. MUMM Policy decision on MARS® National criteria for patient selection Close collaboration with liver transplant unit necessary Treatment in one university hospital (+2 backup) Patient register & regular reports of results ↓ A PhD thesis started on the topic including CEA 7
  • 8. Case 2: National policy 21 Jan 2011 Mäkelä CC seminar 8
  • 9. Obesity surgery • • • • MUMM suggestion in 2007 Important topic, spreading unevenly Scoping: Major ethical issues SII also asked for an HTA → Full HTA as basis for policies • Effectiveness, safety, cost, ethical, social, organisational and legal issues 9
  • 10.
  • 11. Policy options No operations (0-option) 1. Strict criteria: 1500 operations /year 2. International criteria, low demand: 3000/yr 3. International criteria, high demand: 6000/yr Decision for payers 11
  • 12. Each scenario considers • Effects on health care system • Effects on health • Cost impact • Focal points of policy discussion Scenario 2 12
  • 13. Scenario 2 items • • • • • • • 75 000 persons with morbid obesity Willing and suitable for operation: 13 000 Spread over 5 years: 3000 operations yearly Personnel need for operations: 105 py Increased demand for treatment abroad /privately 10-20 operation induced deaths yearly 400 complications, 300 reoperations /yr 13
  • 14. Prioritisation by point system 1. Strict criteria BMI > 45: 50 pts BMI 40-45: 40 pts BMI 35-40: 30 pts BMI points 2. International criteria BMI > 40: 50 pts BMI 35-40: 40 pts Other points Type 2 diabetes: 20 pts Any other disease that Medicated hypertension: 10 pts obesity aggravates: 10 pts Sleep apnea w. CPAP: 10 pts Joint problem needing operation: 10 pts 50 points: Operation indicated 14
  • 15. How does this translate to policy? • Ministry decision on criteria for elective operations • Social insurance decision on coverage Same principles for public and private care 15
  • 16. Two successful examples -why? Policy making structures in place Clear customers for HTA report Inclusive process of HTA and decision making Collaboration and mutual trust between decision makers, clinicians and methodologists Sufficiently rapid reply - patience to wait for it 16
  • 17. Evidence into decisions: Barriers Policy makers ask wrong questions Researchers aim at perfect answers They disagree on timing → Need to develop a shared understanding of HTA use in policy 17
  • 18. Policy implementation: a major challenge HTA producers provide data, not policies May participate in policy formation as experts Post HTA report implementation: national seminar, participation in formulating legislation, national training, producing patient leaflets, web learning materials, effect assessment... 18
  • 19. Values Decision Evidence Resources JA Muir Gray: Evidence Based Health Policy Churchill Livingstone, London 2002 19
  • 21. Thank you! 21 Jan 2011 Mäkelä CC seminar 21